Discovery of Biomarkers for Endometrial Carcinoma

From LEAP

Revision as of 16:25, 9 June 2009 by Bpeat (Talk | contribs)
Jump to: navigation, search

Purpose: Discovering biomarkers for endometrial carcinoma rapidly by direct profiling of proteins in tissue sections.
Methods: nano-scale MALDI-Spotting and MALDI QqTOF mass spectrometry.
Results: Five up-regulated protein markers for endometrial carcinoma were discovered with the new tool.

image:Workflow1.png

Discovery of Biomarkers for Endometrial Carcinoma by Direct Profiling of Proteins in Tissue Sections Using Selective MALDI-SPOTTING and MALDI MS

Jingzhong Guo (1); Muntajib Alhaq (2); Leroi V. DeSouza (1); Gordon Nye (3); Werner Martin (3); Alexander D. Romaschin (4); Terence J. Colgan (2); K..W. Michael Siu (1) 1 York University, Toronto, ON, Canada; 2 Mount Sinai Hospital, Toronto, ON, Canada; 3 LEAP Technologies, Inc., Carrboro, NC; 4 Toronto General Hospital, Toronto, ON, Canada

Introduction In recent years, various technologies have been used to acquire protein profiles (or maps) for biomarker discovery. Many technologies (e.g. 2D PAGE etc.) require multiple steps of sample handling and separation. These steps are time consuming and may lead to protein losses. Direct profiling of proteins in tissue sections provides an alternative and rapid way for biomarker discovery. The challenge is to acquire protein profiles from a user-defined group of cells (e.g. cancer). Here we report our recent work in discovering biomarkers for endometrial carcinoma by direct profiling proteins in tissue sections using a nano-scale MALDI spotter and MS.

Continued in Poster

Reprint of Poster

ASMS 2005 Poster - Discovery of Biomarkers for Endometrial Carcinoma by Direct Profiling of Proteins in Tissue Sections Using Selective MALDI-Spotting and MALDI MS


Contact LEAP

For additional information about this technique please contact LEAP Technologies for detailed information

Contact the LEAP office

Personal tools